Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency: genes and variants
Explore variant evidence for Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency across 2 analyzed proteins (CTLA4, KCNH2). Linked ClinVar records include 14 pathogenic or likely pathogenic variants, 93 variants of uncertain significance and 7 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency
CTLA4: Cytotoxic T-lymphocyte protein 4
It restrains T-cell activation by competing with CD28 for CD80 and CD86 and by delivering inhibitory signals after immune activation. Haploinsufficiency causes immune dysregulation with autoimmunity and lymphoproliferation, while therapeutic blockade enhances antitumor immunity.
13 ClinVar pathogenic / likely pathogenic and 100 uncertain variants in CTLA4 have source records linked to Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency. Association strength is not clinical gene validity.
KCNH2: Voltage-gated inwardly rectifying potassium channel KCNH2
Its unusually rapid inactivation and slow deactivation shape the rapid delayed-rectifier current IKr, a major determinant of ventricular repolarization. Loss-of-function variants can prolong repolarization and cause long-QT syndrome, whereas gain-of-function variants can cause short-QT syndrome.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KCNH2 have source records linked to Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency. Association strength is not clinical gene validity.
Where Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency variants cluster
- CTLA4 Important for interaction with CD80 and CD86 (positions 134–139): 7 of 13 ClinVar pathogenic / likely pathogenic variants, 20.0× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CTLA4 P137R | 137 | Ig-like V-type | Pathogenic / likely pathogenic (★★★) |
| CTLA4 Y139C | 139 | Ig-like V-type | Pathogenic / likely pathogenic (★★★) |
| CTLA4 P137L | 137 | Ig-like V-type | Pathogenic / likely pathogenic (★★★) |
| CTLA4 P136L | 136 | Ig-like V-type | Pathogenic / likely pathogenic (★★★) |
| CTLA4 R75W | 75 | Ig-like V-type | Pathogenic / likely pathogenic (★★★) |
| CTLA4 D153N | 153 | Homodimerization | Pathogenic / likely pathogenic (★★★) |
| CTLA4 R70W | 70 | Ig-like V-type | Pathogenic / likely pathogenic (★★) |
| KCNH2 G572S | 572 | Extracellular | Pathogenic / likely pathogenic (★★) |
| CTLA4 R70Q | 70 | Ig-like V-type | Pathogenic / likely pathogenic (★★) |
| CTLA4 G146R | 146 | Extracellular | Pathogenic / likely pathogenic (★★) |
| CTLA4 Y139S | 139 | Ig-like V-type | Pathogenic / likely pathogenic (★) |
| CTLA4 Y139H | 139 | Ig-like V-type | Pathogenic / likely pathogenic (★) |
| CTLA4 P138T | 138 | Ig-like V-type | Pathogenic / likely pathogenic (★) |
| CTLA4 A54P | 54 | Ig-like V-type | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| CTLA4 P137Q | 137 | Ig-like V-type | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; P137R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.89 |
| CTLA4 P138L | 138 | Ig-like V-type | Uncertain (★) | +6: 7 other pathogenic changes within 3 positions; P138T at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.89 |
Which prediction tools work for Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- PolyPhen-2: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 90 out of 100
- AlphaMissense: 89 out of 100
- MutPred: 78 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 77 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 75 out of 100
- MetaSVM: 75 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 73 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Long QT syndrome also has ClinVar records linked to KCNH2 variants; they fall mostly in different places as the Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency variants (114 pathogenic / likely pathogenic).
- Cardiac arrhythmia also has ClinVar records linked to KCNH2 variants; they fall mostly in different places as the Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency variants (15 pathogenic / likely pathogenic).
- Short QT syndrome also has ClinVar records linked to KCNH2 variants; they fall mostly in different places as the Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency variants (4 pathogenic / likely pathogenic).
Diseases related to Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency
- Long QT syndrome, also linked to KCNH2
- Cardiac arrhythmia, also linked to KCNH2
- Short QT syndrome, also linked to KCNH2
- Non-small cell lung carcinoma, also linked to CTLA4
- Primary familial hypertrophic cardiomyopathy, also linked to KCNH2
- Inherited Immunodeficiency Diseases, also linked to CTLA4
- Hyperthyroidism, also linked to CTLA4
- Type 1 diabetes mellitus, also linked to CTLA4
- Hypothyroidism, also linked to CTLA4
- Hepatocellular carcinoma, also linked to CTLA4
- Basal cell carcinoma, also linked to CTLA4
- Renal cell carcinoma, also linked to CTLA4
Frequently asked questions
Which genes have records linked to Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency?
This view contains 2 analyzed proteins: CTLA4, KCNH2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 14 pathogenic or likely pathogenic variants, 93 variants of uncertain significance and 7 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 135 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center